
DivestmentJun 4, 2026, 04:25 PM
Ekso Bionics Parent to Divest Subsidiary; Focus on Cloud
AI Summary
ChronoScale Corporation, the parent company of Ekso Bionics, Inc., has announced a plan to divest its wholly owned subsidiary, Ekso Bionics, Inc. This strategic move aims to allow ChronoScale to focus its operations solely on its cloud business. The divestiture is expected to be completed during the first fiscal quarter, and ChronoScale anticipates incurring material charges, including severance and lease termination costs, though specific estimates are not yet available.
Key Highlights
- ChronoScale Corporation to divest its wholly owned subsidiary, Ekso Bionics, Inc.
- Divestment allows ChronoScale to focus solely on its cloud business.
- Expected completion of divestiture is during the first fiscal quarter.
- Material charges anticipated, including severance and lease termination costs.
- Specific estimates for charges are not yet available.
Price Impact
More from EKSO